VITAE INDUSTRIES, INC.

PROVIDENCE, X1 · Founded 2014 · Medtech · Acquired

Software platform for healthcare professionals to manage high-risk patient groups, integrated with medical care delivery services

Claim this profile

Follows are private to you and power your alerts

Updated · vitae.health

Sector
Medtech
Headquarters
PROVIDENCE, X1
Founded
2014
Latest Form D
$2.3M, Aug 2017
Total capital
$2.7M
Federal grants
$149K
1 award · 2018
Rank in peer group#36 of 1112
Private capital raised
$2.5M
3 Form D · last Aug 2017
110 months since last filing
Federal contracts
None on recordNo federal contract awards found.
Granted patents
2
5 pending · first 2022
Rank in peer group#425 of 1112

Capital timeline

201620172018FEDERAL ↑EQUITY ↓Cumulative $2.7M$149K1st Form D$20K2nd Form D$200K3rd Form D$2.3M
201620172018FEDERAL ↑EQUITY ↓Cumulative $2.7M$149K1st Form D$20K3rd Form D$2.3M

Latest events

  • Federal grantHealth and Human S · Phase I · A cost-effective robotic platform for on-demand production of flexibly dosed medications in a chewable gummy dosage form$149K
  • Private capital raisedForm D · SEC · 3rd filing$2.3M
  • Private capital raisedForm D · SEC · 2nd filing$200K
  • Private capital raisedForm D · SEC · 1st filing$20K

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Standing among 1112 peers

Line = median

Medtech · Device

  • Federal grants#36 · top 3%
  • Granted patents#425 · top 38%

Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.

Founders and team

From SEC Form D filings
  • Daniel DeCiccioExecutive Officer, DirectorNamed in SEC Form D filings
  • Jeanine Sinanan-SinghExecutive Officer, DirectorNamed in SEC Form D filings

What it has protected

USPTO · 2 granted of 7
Show all 7 patent records
  • Pharmacy Fulfillment And Verification Of Non-sterile CompoundingMay 30, 2023 · US 11,664,102Granted
  • Method and apparatus for sterilized 3d printingMar 29, 2022 · US 11,285,228Granted
  • Systems For Making Personalized MedicineDec 5, 2019 · Application 16439077Pending
  • Method And Apparatus For Safe And Accurate 3D PrintingOct 11, 2018 · Application 15887804Pending
  • Systems For Making Personalized MedicineNov 24, 2016 · Application 15162168Pending
  • Method And Apparatus For Safe And Accurate 3D PrintingApplication 62454286Pending
  • Self-contained Sterilizing 3D PrinterApplication 62251318Pending
  • HumanImage IncSimilar federal contract value in Medtech · null in contracts
  • CryOSA, Inc.Similar federal contract value in Medtech · null in contracts
  • SPINAL SINGULARITY, INC.Similar federal contract value in Medtech · null in contracts
  • BAMF Health Parent, Inc.Similar federal contract value in Medtech · null in contracts
  • Infinant Health, Inc.Similar federal contract value in Medtech · null in contracts
  • Valius Health, Inc.Similar federal contract value in Medtech · null in contracts

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through . SBIR and STTR awards through .